Australia’s largest intellectual property services firm IPH will maintain its dominance after winning a takeover battle for Xenith IP, a deal that will create a formidable IP services giant with over 1,000 employees across Asia Pacific.
RCR Tomlinson class actions will fight to stay alive
ACCC accuses iSelect of misleading customers over cheapest energy plans
Judge shoots down Mylan bid for generic Lipidil injunction
A judge has denied Mylan’s bid to temporarily block Sun Pharma and Cipla from making generic versions of anti-cholesterol drug Lipidil while it appeals a ruling invalidating several claims of its patents for the drug, citing the “difficulty, complexity and uncertainty” in assessing compensation under an undertaking as to damages in pharmaceutical patent proceedings.